| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Athletes | 7 | 2019 | 1047 | 1.66 | Why? |
| Circadian Rhythm | 4 | 2020 | 607 | 1.49 | Why? |
| Skiing | 3 | 2018 | 19 | 1.32 | Why? |
| Volleyball | 2 | 2019 | 13 | 0.97 | Why? |
| Bone and Bones | 3 | 2019 | 235 | 0.86 | Why? |
| Muscle Strength | 2 | 2020 | 317 | 0.86 | Why? |
| Hydrocortisone | 3 | 2019 | 1790 | 0.76 | Why? |
| Photoperiod | 1 | 2018 | 41 | 0.74 | Why? |
| Phlebotomy | 2 | 2018 | 131 | 0.70 | Why? |
| alpha-Defensins | 1 | 2017 | 35 | 0.70 | Why? |
| Metal-on-Metal Joint Prostheses | 1 | 2017 | 7 | 0.69 | Why? |
| Osteocalcin | 1 | 2017 | 31 | 0.69 | Why? |
| Postural Balance | 1 | 2018 | 144 | 0.69 | Why? |
| Resistance Training | 1 | 2020 | 273 | 0.69 | Why? |
| Bone Morphogenetic Proteins | 1 | 2017 | 25 | 0.68 | Why? |
| Hip Prosthesis | 1 | 2017 | 54 | 0.66 | Why? |
| Prosthesis-Related Infections | 2 | 2017 | 302 | 0.66 | Why? |
| Pre-Analytical Phase | 1 | 2017 | 36 | 0.66 | Why? |
| Range of Motion, Articular | 1 | 2017 | 168 | 0.64 | Why? |
| Posture | 1 | 2018 | 199 | 0.64 | Why? |
| Osteoarthritis, Hip | 1 | 2017 | 56 | 0.64 | Why? |
| Laboratories, Hospital | 2 | 2018 | 489 | 0.63 | Why? |
| Pathologists | 1 | 2017 | 168 | 0.62 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.62 | Why? |
| Lower Extremity | 3 | 2018 | 593 | 0.62 | Why? |
| Vitamin D | 4 | 2021 | 2904 | 0.59 | Why? |
| Seasons | 4 | 2017 | 4071 | 0.58 | Why? |
| Hematologic Tests | 5 | 2020 | 521 | 0.58 | Why? |
| Reticulocyte Count | 2 | 2013 | 7 | 0.56 | Why? |
| Nurse Practitioners | 1 | 2018 | 248 | 0.55 | Why? |
| Substance Abuse Detection | 3 | 2018 | 192 | 0.54 | Why? |
| Imagination | 3 | 2018 | 25 | 0.53 | Why? |
| Muscle, Skeletal | 2 | 2018 | 915 | 0.52 | Why? |
| Cryotherapy | 1 | 2013 | 31 | 0.51 | Why? |
| Motor Cortex | 3 | 2018 | 71 | 0.51 | Why? |
| Patient Reported Outcome Measures | 1 | 2019 | 912 | 0.49 | Why? |
| Clinical Laboratory Services | 3 | 2019 | 781 | 0.48 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2017 | 403 | 0.45 | Why? |
| Hematology | 1 | 2018 | 649 | 0.44 | Why? |
| Football | 1 | 2013 | 120 | 0.44 | Why? |
| Musculoskeletal Diseases | 1 | 2019 | 646 | 0.44 | Why? |
| Athletic Injuries | 1 | 2013 | 208 | 0.42 | Why? |
| Machine Learning | 4 | 2020 | 4395 | 0.42 | Why? |
| Reticulocytes | 1 | 2010 | 55 | 0.41 | Why? |
| Doping in Sports | 1 | 2010 | 45 | 0.41 | Why? |
| Soccer | 3 | 2019 | 259 | 0.40 | Why? |
| Exercise | 3 | 2018 | 6771 | 0.38 | Why? |
| Emergencies | 2 | 2021 | 4095 | 0.38 | Why? |
| Chemistry, Clinical | 2 | 2019 | 34 | 0.37 | Why? |
| Collagen Type II | 2 | 2017 | 12 | 0.36 | Why? |
| Driving Under the Influence | 2 | 2018 | 24 | 0.36 | Why? |
| Hemoglobins | 2 | 2013 | 958 | 0.34 | Why? |
| Connectome | 2 | 2018 | 67 | 0.34 | Why? |
| Point-of-Care Testing | 2 | 2017 | 2782 | 0.34 | Why? |
| Physical Endurance | 2 | 2018 | 107 | 0.33 | Why? |
| Gait | 2 | 2018 | 137 | 0.33 | Why? |
| Osteoarthritis | 2 | 2020 | 205 | 0.31 | Why? |
| Lipopolysaccharide Receptors | 2 | 2019 | 357 | 0.31 | Why? |
| Athletic Performance | 2 | 2018 | 208 | 0.29 | Why? |
| Exercise Test | 3 | 2019 | 911 | 0.27 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.27 | Why? |
| Arthritis, Psoriatic | 2 | 2021 | 625 | 0.26 | Why? |
| Peptide Fragments | 3 | 2019 | 2075 | 0.26 | Why? |
| Blood Specimen Collection | 2 | 2018 | 387 | 0.26 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.24 | Why? |
| Italy | 12 | 2021 | 38444 | 0.21 | Why? |
| Zebrafish | 2 | 2019 | 181 | 0.21 | Why? |
| Running | 2 | 2019 | 153 | 0.20 | Why? |
| Piperacillin | 1 | 2019 | 63 | 0.19 | Why? |
| Brain Mapping | 2 | 2017 | 228 | 0.19 | Why? |
| Bone Resorption | 1 | 2019 | 61 | 0.19 | Why? |
| Lipocalin-2 | 2 | 2017 | 156 | 0.19 | Why? |
| Gyrus Cinguli | 1 | 2018 | 28 | 0.19 | Why? |
| Reproducibility of Results | 5 | 2021 | 11304 | 0.19 | Why? |
| Visual Analog Scale | 1 | 2019 | 151 | 0.19 | Why? |
| Photic Stimulation | 1 | 2018 | 74 | 0.19 | Why? |
| Actigraphy | 1 | 2019 | 102 | 0.18 | Why? |
| Butyric Acid | 1 | 2018 | 27 | 0.18 | Why? |
| Registries | 1 | 2019 | 12327 | 0.18 | Why? |
| Spinal Osteochondrosis | 1 | 2017 | 1 | 0.18 | Why? |
| Synovitis | 1 | 2018 | 47 | 0.18 | Why? |
| Blood Alcohol Content | 1 | 2017 | 9 | 0.18 | Why? |
| Motion Perception | 1 | 2017 | 4 | 0.18 | Why? |
| Biological Clocks | 1 | 2017 | 10 | 0.18 | Why? |
| Models, Neurological | 1 | 2018 | 121 | 0.18 | Why? |
| Diffusion Tensor Imaging | 1 | 2018 | 125 | 0.18 | Why? |
| Neurotransmitter Agents | 1 | 2018 | 57 | 0.18 | Why? |
| Physical Conditioning, Human | 1 | 2018 | 57 | 0.18 | Why? |
| Glycyrrhiza | 1 | 2019 | 141 | 0.18 | Why? |
| Hand Joints | 1 | 2017 | 31 | 0.18 | Why? |
| Linezolid | 1 | 2019 | 160 | 0.17 | Why? |
| Resistin | 1 | 2017 | 16 | 0.17 | Why? |
| Flavanones | 1 | 2019 | 141 | 0.17 | Why? |
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 30 | 0.17 | Why? |
| Tourette Syndrome | 1 | 2017 | 41 | 0.17 | Why? |
| Janus Kinases | 1 | 2021 | 414 | 0.17 | Why? |
| Humans | 55 | 2021 | 930598 | 0.17 | Why? |
| Cartilage, Articular | 1 | 2017 | 50 | 0.17 | Why? |
| Mobility Limitation | 1 | 2018 | 153 | 0.17 | Why? |
| Intervertebral Disc Degeneration | 1 | 2017 | 31 | 0.17 | Why? |
| Rest | 1 | 2018 | 188 | 0.17 | Why? |
| SARS Virus | 1 | 2021 | 13021 | 0.17 | Why? |
| Osteosarcoma | 1 | 2018 | 83 | 0.17 | Why? |
| Hip Joint | 1 | 2017 | 59 | 0.17 | Why? |
| Receptors, Calcitriol | 1 | 2017 | 102 | 0.16 | Why? |
| Neuronal Plasticity | 1 | 2017 | 98 | 0.16 | Why? |
| Teicoplanin | 1 | 2019 | 191 | 0.16 | Why? |
| Body Composition | 1 | 2020 | 414 | 0.16 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.16 | Why? |
| Diet, High-Fat | 1 | 2017 | 161 | 0.16 | Why? |
| Biomarkers | 9 | 2020 | 23361 | 0.16 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2018 | 238 | 0.16 | Why? |
| Sleep | 2 | 2020 | 2695 | 0.16 | Why? |
| Fibronectins | 1 | 2017 | 92 | 0.16 | Why? |
| Spinal Fractures | 1 | 2018 | 124 | 0.16 | Why? |
| Proteolysis | 2 | 2017 | 751 | 0.16 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.16 | Why? |
| Blood Chemical Analysis | 1 | 2020 | 541 | 0.16 | Why? |
| Thyroxine | 1 | 2018 | 250 | 0.15 | Why? |
| Accidents, Traffic | 2 | 2018 | 464 | 0.15 | Why? |
| Light | 1 | 2018 | 306 | 0.15 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.15 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.15 | Why? |
| Osteoporotic Fractures | 1 | 2018 | 175 | 0.15 | Why? |
| Motor Activity | 1 | 2017 | 217 | 0.15 | Why? |
| Postmenopause | 1 | 2017 | 160 | 0.15 | Why? |
| Prosthesis Failure | 1 | 2017 | 195 | 0.15 | Why? |
| Accidental Falls | 1 | 2019 | 448 | 0.14 | Why? |
| Adult | 21 | 2021 | 244371 | 0.14 | Why? |
| Gonadal Steroid Hormones | 1 | 2017 | 328 | 0.14 | Why? |
| Physical Fitness | 1 | 2017 | 334 | 0.14 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.13 | Why? |
| Young Adult | 13 | 2019 | 93724 | 0.13 | Why? |
| Male | 31 | 2021 | 367725 | 0.13 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.13 | Why? |
| Cyclosporine | 1 | 2017 | 449 | 0.13 | Why? |
| Female | 27 | 2021 | 380317 | 0.13 | Why? |
| Transferrin | 1 | 2013 | 90 | 0.13 | Why? |
| Hematocrit | 1 | 2013 | 107 | 0.13 | Why? |
| Bias | 1 | 2019 | 1109 | 0.12 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.12 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.12 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.12 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.12 | Why? |
| Magnetic Resonance Imaging | 6 | 2018 | 6551 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.12 | Why? |
| Erythrocyte Count | 1 | 2013 | 137 | 0.12 | Why? |
| Radiography | 2 | 2018 | 1576 | 0.12 | Why? |
| Dendritic Cells | 1 | 2021 | 1330 | 0.12 | Why? |
| Phytotherapy | 1 | 2019 | 743 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.11 | Why? |
| Testosterone | 1 | 2017 | 596 | 0.11 | Why? |
| Adolescent | 12 | 2019 | 86841 | 0.11 | Why? |
| Chromatography, Liquid | 3 | 2019 | 640 | 0.11 | Why? |
| Sports | 1 | 2018 | 690 | 0.10 | Why? |
| Brain | 2 | 2018 | 5133 | 0.10 | Why? |
| Root Canal Therapy | 1 | 2009 | 8 | 0.10 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Blood Glucose | 3 | 2019 | 3642 | 0.10 | Why? |
| California | 1 | 2017 | 2047 | 0.10 | Why? |
| Telephone | 1 | 2019 | 1705 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.10 | Why? |
| Data Collection | 1 | 2019 | 1769 | 0.10 | Why? |
| Intention | 1 | 2018 | 1380 | 0.09 | Why? |
| Endodontics | 1 | 2009 | 61 | 0.09 | Why? |
| Alkaline Phosphatase | 2 | 2020 | 257 | 0.09 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.09 | Why? |
| Sleep Wake Disorders | 1 | 2020 | 1463 | 0.09 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.09 | Why? |
| Parathyroid Hormone | 2 | 2019 | 98 | 0.09 | Why? |
| Hyperglycemia | 1 | 2019 | 1363 | 0.09 | Why? |
| Tandem Mass Spectrometry | 3 | 2019 | 1031 | 0.09 | Why? |
| L-Lactate Dehydrogenase | 3 | 2020 | 1995 | 0.09 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.08 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.08 | Why? |
| Time Factors | 4 | 2019 | 31397 | 0.08 | Why? |
| Longitudinal Studies | 4 | 2020 | 9893 | 0.08 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.08 | Why? |
| Aged | 15 | 2021 | 215776 | 0.08 | Why? |
| Movement | 2 | 2018 | 232 | 0.08 | Why? |
| Diet | 1 | 2018 | 2052 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.07 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.07 | Why? |
| Bone Density | 2 | 2018 | 335 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Academic Medical Centers | 1 | 2017 | 3088 | 0.07 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.07 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.07 | Why? |
| Alanine Transaminase | 2 | 2020 | 1329 | 0.07 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.07 | Why? |
| Ferritins | 1 | 2013 | 2055 | 0.07 | Why? |
| Antirheumatic Agents | 1 | 2018 | 3023 | 0.06 | Why? |
| Aspartate Aminotransferases | 2 | 2020 | 1394 | 0.06 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.06 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.06 | Why? |
| Psoriasis | 1 | 2017 | 1739 | 0.06 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.06 | Why? |
| C-Reactive Protein | 4 | 2020 | 7972 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.06 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Area Under Curve | 2 | 2020 | 2564 | 0.06 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.06 | Why? |
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2021 | 65 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Toll-Like Receptor 9 | 1 | 2021 | 72 | 0.05 | Why? |
| Models, Statistical | 1 | 2019 | 5312 | 0.05 | Why? |
| Immunoassay | 1 | 2017 | 4485 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.05 | Why? |
| Oligonucleotides | 1 | 2021 | 137 | 0.05 | Why? |
| gamma-Glutamyltransferase | 1 | 2020 | 101 | 0.05 | Why? |
| Tartrate-Resistant Acid Phosphatase | 1 | 2019 | 7 | 0.05 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.05 | Why? |
| Phosphodiesterase 4 Inhibitors | 1 | 2021 | 112 | 0.05 | Why? |
| Osteoclasts | 1 | 2019 | 67 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Analgesics, Non-Narcotic | 1 | 2020 | 164 | 0.05 | Why? |
| Blood Platelets | 2 | 2020 | 1704 | 0.05 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.05 | Why? |
| Plant Roots | 1 | 2019 | 108 | 0.05 | Why? |
| Biogenic Amines | 1 | 2018 | 13 | 0.05 | Why? |
| Osteoblasts | 1 | 2019 | 87 | 0.05 | Why? |
| Weight Lifting | 1 | 2018 | 9 | 0.05 | Why? |
| Glycation End Products, Advanced | 1 | 2019 | 72 | 0.05 | Why? |
| Warm-Up Exercise | 1 | 2018 | 19 | 0.05 | Why? |
| Forensic Toxicology | 1 | 2018 | 27 | 0.05 | Why? |
| Algorithms | 2 | 2020 | 7346 | 0.05 | Why? |
| gamma-Aminobutyric Acid | 1 | 2018 | 52 | 0.05 | Why? |
| Glutamic Acid | 1 | 2018 | 65 | 0.05 | Why? |
| Acetylcholine | 1 | 2018 | 53 | 0.05 | Why? |
| Sleep Hygiene | 1 | 2019 | 91 | 0.04 | Why? |
| Histamine | 1 | 2018 | 61 | 0.04 | Why? |
| Food Analysis | 1 | 2018 | 53 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 13720 | 0.04 | Why? |
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2017 | 40 | 0.04 | Why? |
| Competitive Behavior | 1 | 2019 | 111 | 0.04 | Why? |
| Sensitivity and Specificity | 4 | 2020 | 22971 | 0.04 | Why? |
| Equipment Failure | 1 | 2019 | 197 | 0.04 | Why? |
| Dopamine | 1 | 2018 | 123 | 0.04 | Why? |
| Psychomotor Performance | 1 | 2018 | 110 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2018 | 75 | 0.04 | Why? |
| Ankle | 1 | 2017 | 66 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Serotonin | 1 | 2018 | 137 | 0.04 | Why? |
| Osteopontin | 1 | 2017 | 96 | 0.04 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 198 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Animals | 4 | 2019 | 78931 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2017 | 211 | 0.04 | Why? |
| Toll-Like Receptor 2 | 1 | 2017 | 198 | 0.04 | Why? |
| Thyroid Function Tests | 1 | 2017 | 200 | 0.04 | Why? |
| Clinical Studies as Topic | 1 | 2017 | 118 | 0.04 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.04 | Why? |
| Thyrotropin | 1 | 2018 | 262 | 0.04 | Why? |
| Thyroidectomy | 1 | 2018 | 207 | 0.04 | Why? |
| Foot | 1 | 2017 | 195 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2018 | 53120 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.04 | Why? |
| Chemotherapy, Adjuvant | 1 | 2018 | 606 | 0.04 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.04 | Why? |
| Piperidines | 1 | 2021 | 795 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Case-Control Studies | 3 | 2017 | 17671 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| NF-kappa B | 1 | 2021 | 1301 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Datasets as Topic | 1 | 2020 | 1404 | 0.03 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Receptors, Cell Surface | 1 | 2017 | 586 | 0.03 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.03 | Why? |
| Stress, Psychological | 1 | 2017 | 10231 | 0.03 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.03 | Why? |
| Inventions | 1 | 2017 | 372 | 0.03 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Antigens, CD | 1 | 2017 | 984 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Neurons | 1 | 2018 | 864 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.03 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2021 | 1585 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Troponin | 1 | 2017 | 1058 | 0.03 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.03 | Why? |
| Limit of Detection | 1 | 2019 | 2698 | 0.03 | Why? |
| Lenses | 1 | 2009 | 5 | 0.03 | Why? |
| Analgesics, Opioid | 1 | 2020 | 1070 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2017 | 1215 | 0.02 | Why? |
| Endoscopes | 1 | 2009 | 72 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Virtual Reality | 1 | 2017 | 640 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Gene Expression | 1 | 2019 | 3332 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.02 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Plant Extracts | 1 | 2019 | 1514 | 0.02 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.02 | Why? |
| Diabetes Complications | 1 | 2019 | 2358 | 0.02 | Why? |
| Organizational Innovation | 1 | 2017 | 2468 | 0.02 | Why? |
| Microscopy | 1 | 2009 | 414 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.02 | Why? |
| Life Style | 1 | 2017 | 2708 | 0.02 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.01 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.01 | Why? |
| Critical Care | 1 | 2019 | 14081 | 0.01 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |